Nimodipine in patients with heart disease.
Roine
R O
RO
D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D002986:Clinical Trials as Topic; D000075202:Contraindications; D003327:Coronary Disease / Q000209:etiology / Q000401:mortality*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D015201:Meta-Analysis as Topic; D015337:Multicenter Studies as Topic; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000627:therapeutic use; D009543:Nifedipine / Q000009:adverse effects*; D009553:Nimodipine / Q000009:adverse effects* / Q000627:therapeutic use; D016019:Survival Analysis; D016896:Treatment Outcome; D014693:Ventricular Fibrillation / Q000188:drug therapy
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D018696:Neuroprotective Agents; D009553:Nimodipine; D009543:Nifedipine